is a drug discovery company focused on neurodegenerative disease. Cajal is inspired by the pioneering work of Nobel laureate Santiago Ramón y Cajal who illuminated the complexity of the brain by marrying art and science.
Location: United States, Washington, Seattle
Total raised: $96M
Investors 3
Date | Name | Website |
26.02.2021 | Dolby Fami... | dolbyventu... |
22.11.2023 | Two Sigma ... | twosigmave... |
28.10.2020 | Lux Capita... | luxcapital... |
Funding Rounds 1
Date | Series | Amount | Investors |
29.11.2022 | Series A | $96M | - |
Mentions in press and media 6
Date | Title | Description | Source |
23.01.2023 | Startups measuring the brain that you need to know | Companies are using biomarkers to diagnose and treat mental illness and other neurological disorders... | vator.tv/n... |
29.11.2022 | Cajal Neuroscience Raises $96M in Series A Funding | Cajal Neuroscience, a Seattle, WA-based biotechnology company, raised $96M in Series A funding. The... | finsmes.co... |
29.11.2022 | Cajal Neuroscience Launches with $96 Million to Transform Ta... | - | dolbyventu... |
29.11.2022 | Seattle startup with fresh approach to Parkinson’s and Alzhe... | Microscopy image of neurons in the mouse brain. (Cajal Neuroscience Image) Cajal Neuroscience, a Se... | geekwire.c... |
14.01.2022 | Our 2021 Predictions Report Card: How Accurate Were We? | Each year we pause to reflect on what happened in the tech and VC space and share new predictions fo... | twosigmave... |
- | Cajal Neuroscience | “Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.” | fastfounde... |